Life Stance Health Group, Inc. LFST
We take great care to ensure that the data presented and summarized in this overview for LifeStance Health Group, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding LFST
View all-
Tpg Gp A, LLC Fort Worth, TX161MShares$1.03 Billion57.22% of portfolio
-
Summit Partners L P33.5MShares$215 Million56.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$93.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.36MShares$53.5 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$53.3 Million0.0% of portfolio
-
Jennison Associates LLC7.43MShares$47.6 Million0.02% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL4.79MShares$30.7 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.96MShares$25.4 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY3.57MShares$22.8 Million0.0% of portfolio
-
Barclays PLC London, X03.51MShares$22.5 Million0.0% of portfolio
Latest Institutional Activity in LFST
Top Purchases
Top Sells
About LFST
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
Insider Transactions at LFST
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2025
|
Robert Bessler |
SELL
Open market or private sale
|
Indirect |
1,701
-0.06%
|
$11,907
$7.04 P/Share
|
|
Dec 19
2025
|
Robert Bessler |
SELL
Open market or private sale
|
Indirect |
119,942
-4.18%
|
$839,594
$7.04 P/Share
|
|
Dec 18
2025
|
Robert Bessler |
SELL
Open market or private sale
|
Indirect |
6,442
-0.22%
|
$45,094
$7.0 P/Share
|
|
Dec 17
2025
|
Ann Varanakis Chief People Officer |
SELL
Open market or private sale
|
Direct |
50,000
-13.68%
|
$300,000
$6.9 P/Share
|
|
Dec 15
2025
|
Robert Bessler |
SELL
Open market or private sale
|
Indirect |
12,371
-0.43%
|
$86,597
$7.0 P/Share
|
|
Dec 12
2025
|
Robert Bessler |
SELL
Open market or private sale
|
Indirect |
79,630
-2.69%
|
$557,410
$7.01 P/Share
|
|
Nov 21
2025
|
Lisa K Miller |
SELL
Open market or private sale
|
Direct |
57,240
-17.97%
|
$343,440
$6.43 P/Share
|
|
Nov 10
2025
|
Lisa K Miller |
SELL
Payment of exercise price or tax liability
|
Direct |
10,623
-3.23%
|
$63,738
$6.43 P/Share
|
|
Aug 26
2025
|
Ann Varanakis Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,233
-1.4%
|
$26,165
$5.39 P/Share
|
|
Aug 20
2025
|
Sarah Personette |
BUY
Grant, award, or other acquisition
|
Direct |
74,766
+50.0%
|
-
|
|
Aug 18
2025
|
Darren M. Black |
SELL
Open market or private sale
|
Indirect |
8,407,643
-20.05%
|
$42,038,215
$5.07 P/Share
|
|
Aug 18
2025
|
Silversmith Partners I Gp, LLC |
SELL
Open market or private sale
|
Indirect |
3,592,357
-20.05%
|
$17,961,785
$5.07 P/Share
|
|
Aug 18
2025
|
Summit Partners L P |
SELL
Open market or private sale
|
Direct |
8,407,643
-20.05%
|
$42,038,215
$5.07 P/Share
|
|
Aug 11
2025
|
Kenneth A Burdick |
BUY
Open market or private purchase
|
Direct |
20,000
+0.29%
|
$80,000
$4.45 P/Share
|
|
Aug 08
2025
|
Kenneth A Burdick |
BUY
Open market or private purchase
|
Indirect |
46,511
+50.0%
|
$186,044
$4.3 P/Share
|
|
Aug 08
2025
|
Kenneth A Burdick |
BUY
Open market or private purchase
|
Direct |
47,670
+0.69%
|
$190,680
$4.34 P/Share
|
|
Jun 16
2025
|
Ujjwal Ramtekkar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,519
-8.39%
|
$47,595
$5.17 P/Share
|
|
Jun 11
2025
|
Teresa De Luca |
BUY
Grant, award, or other acquisition
|
Direct |
35,714
+24.97%
|
-
|
|
Jun 11
2025
|
Robert Bessler |
BUY
Grant, award, or other acquisition
|
Direct |
35,714
+38.27%
|
-
|
|
Jun 11
2025
|
Eric Shuey |
BUY
Grant, award, or other acquisition
|
Direct |
35,714
+27.54%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 2.77M shares |
|---|---|
| Open market or private purchase | 114K shares |
| Payment of exercise price or tax liability | 704K shares |
|---|---|
| Open market or private sale | 20.8M shares |